South Korea · Delayed Price · Currency is KRW JW Pharmaceutical Statistics
Total Valuation
KRX:001060 has a market cap or net worth of KRW 729.69 billion. The enterprise value is 722.98 billion.
| Market Cap | 729.69B |
| Enterprise Value | 722.98B |
Important Dates
The last earnings date was Friday, March 20, 2026.
| Earnings Date | Mar 20, 2026 |
| Ex-Dividend Date | Mar 31, 2026 |
Share Statistics
KRX:001060 has 22.89 million shares outstanding. The number of shares has decreased by -1.32% in one year.
| Current Share Class | 22.55M |
| Shares Outstanding | 22.89M |
| Shares Change (YoY) | -1.32% |
| Shares Change (QoQ) | +22.32% |
| Owned by Insiders (%) | 0.81% |
| Owned by Institutions (%) | 8.23% |
| Float | 12.90M |
Valuation Ratios
The trailing PE ratio is 12.61.
| PE Ratio | 12.61 |
| Forward PE | n/a |
| PS Ratio | 0.94 |
| PB Ratio | 1.98 |
| P/TBV Ratio | 2.05 |
| P/FCF Ratio | 8.62 |
| P/OCF Ratio | 7.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.64, with an EV/FCF ratio of 8.54.
| EV / Earnings | 11.75 |
| EV / Sales | 0.93 |
| EV / EBITDA | 6.64 |
| EV / EBIT | 8.02 |
| EV / FCF | 8.54 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.15.
| Current Ratio | 1.42 |
| Quick Ratio | 0.86 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | 0.51 |
| Debt / FCF | 0.65 |
| Interest Coverage | 19.86 |
Financial Efficiency
Return on equity (ROE) is 17.60% and return on invested capital (ROIC) is 17.31%.
| Return on Equity (ROE) | 17.60% |
| Return on Assets (ROA) | 9.08% |
| Return on Invested Capital (ROIC) | 17.31% |
| Return on Capital Employed (ROCE) | 22.18% |
| Weighted Average Cost of Capital (WACC) | 10.29% |
| Revenue Per Employee | 725.93M |
| Profits Per Employee | 57.59M |
| Employee Count | 1,068 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 3.75 |
Taxes
In the past 12 months, KRX:001060 has paid 27.32 billion in taxes.
| Income Tax | 27.32B |
| Effective Tax Rate | 30.76% |
Stock Price Statistics
The stock price has increased by +45.56% in the last 52 weeks. The beta is 1.16, so KRX:001060's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | +45.56% |
| 50-Day Moving Average | 31,525.00 |
| 200-Day Moving Average | 25,480.75 |
| Relative Strength Index (RSI) | 48.59 |
| Average Volume (20 Days) | 101,501 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:001060 had revenue of KRW 775.30 billion and earned 61.51 billion in profits. Earnings per share was 2,534.00.
| Revenue | 775.30B |
| Gross Profit | 359.31B |
| Operating Income | 87.88B |
| Pretax Income | 88.84B |
| Net Income | 61.51B |
| EBITDA | 106.62B |
| EBIT | 87.88B |
| Earnings Per Share (EPS) | 2,534.00 |
Balance Sheet
The company has 61.34 billion in cash and 54.63 billion in debt, with a net cash position of 6.71 billion or 293.01 per share.
| Cash & Cash Equivalents | 61.34B |
| Total Debt | 54.63B |
| Net Cash | 6.71B |
| Net Cash Per Share | 293.01 |
| Equity (Book Value) | 369.37B |
| Book Value Per Share | 13,194.16 |
| Working Capital | 87.35B |
Cash Flow
In the last 12 months, operating cash flow was 96.40 billion and capital expenditures -11.77 billion, giving a free cash flow of 84.62 billion.
| Operating Cash Flow | 96.40B |
| Capital Expenditures | -11.77B |
| Depreciation & Amortization | 18.75B |
| Net Borrowing | -39.17B |
| Free Cash Flow | 84.62B |
| FCF Per Share | 3,697.50 |
Margins
Gross margin is 46.35%, with operating and profit margins of 11.33% and 7.93%.
| Gross Margin | 46.35% |
| Operating Margin | 11.33% |
| Pretax Margin | 11.46% |
| Profit Margin | 7.93% |
| EBITDA Margin | 13.75% |
| EBIT Margin | 11.33% |
| FCF Margin | 10.92% |
Dividends & Yields
This stock pays an annual dividend of 450.00, which amounts to a dividend yield of 1.41%.
| Dividend Per Share | 450.00 |
| Dividend Yield | 1.41% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 9 |
| Payout Ratio | 17.99% |
| Buyback Yield | 1.32% |
| Shareholder Yield | 2.77% |
| Earnings Yield | 8.43% |
| FCF Yield | 11.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 27, 2023 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
KRX:001060 has an Altman Z-Score of 3.79 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.79 |
| Piotroski F-Score | 6 |